Class III Obesity and its Relationship with the Nutritional Status of Vitamin A in Pre- and Postoperative Gastric Bypass
- 320 Downloads
Epidemiological findings have shown the rise of the prevalence of obesity in several segments of the world population, and more recent evidences point to a possible association with vitamin A deficiency (VAD). The aim of this study was to investigate vitamin A nutritional status in individuals with class III obesity in the preoperative period and 30 and 180 days after Roux-en-Y gastric bypass, correlating these findings with lipid profile and body mass index (BMI).
The sample was composed of class III obese individuals, males and females, in the preoperative period (T1) and 30 (T2) and 180 days (T3) after bariatric surgery with 5,000 IU of supplementation of retinol acetate. Vitamin A nutritional status was assessed through biochemical indicators (retinol and β-carotene serum levels), which were quantified by high-performance liquid chromatography with an inadequacy cutoff of <1.05 μmol/L and ≥40 μg/dL, respectively.
Out of the 114 assessed patients, the mean age was 36.9 ± 11.6 years and BMI was ≥40 kg/m2. The prevalence of VAD was 14%, being 37.5% in T1, 50.8% and 67.8% in T2, and 52.9% and 67% in T3, according to retinol and serum β-carotene, respectively. A decrease of retinol and β-carotene serum levels was observed with BMI increase in T1. An increase of very-low-density lipoprotein cholesterol (VLDLc) and triglycerides was verified with the increase of retinol, being VLDLc in T3 and triglycerides in T1 and T2. In T1, high-dense lipoprotein cholesterol presented a positive and significant correlation with β-carotene and a negative and significant correlation in T3.
High prevalence of VAD in the preoperative period and in 30 and 180 postoperative days, even during supplementation, with higher inadequacy of β-carotene in all the three studied time periods, probably occurred because of its bioconversion to retinol due to the increased demand to which those individuals were exposed. It is suggested that the oral intake supplementation does not present the expected impact, and the need of assessing the nutritional status of vitamin A in the pre- and postoperative Roux-en-Y gastric bypass is emphasized. High prevalence of VAD in T1, with severity in T2 and T3, corroborates the utilization of the cutoff of <1.05 μmol/L as a VAD marker in the studied segment and reinforces its utilization as a tool in clinical practice to identify VAD in morbid obese patients who underwent bariatric surgery.
KeywordsVitamin A Retinol β-carotene Morbid obesity Gastric bypass
- 1.Halpen A. Fisiologia da Obesidade (Physiology of Obesity). In: Garrido Júnior AB, Ferraz EM, Barroso FL, et al., editors. Cirurgia da obesidade (Obesity Surgery). São Paulo: Atheneu; 2003. p. 9–12.Google Scholar
- 3.Fundação Instituto Brasileiro de Geografia e Estatística (IBGE). Pesquisa de orçamentos familiares 2002–2003: Análise da disponibilidade domiciliar de alimentos e do estado nutricional no Brasil (Research of family budgets: 2002–2003: Analysis of home availability of foods and of the nutritional status in Brazil). Rio de Janeiro: Ministério do Planejamento e Orçamento/IBGE; 2004.Google Scholar
- 5.Coutinho WF, Benchimol AK. Obesidade mórbida e afecções associadas (Morbid obesity and associated infections). In: Garrrido-Júnior AB, Ferraz EM, Barroso FL, et al., editors. Cirurgia da obesidade (Obesity Surgery). São Paulo: Ed Atheneu; 2003. p. 13–7.Google Scholar
- 12.United Nations Children’s Fund. Vitamin A and mineral deficiency: a global assessment. New York; 2004.Google Scholar
- 13.Institute of Medicine. Vitamin A. In: Dietary reference intakes for vitamin A, vitamin K, arsenic, boron, chromium, copper, iodine, iron, manganese, molybdenum, nickel, silicon, vanadium, and zinc. Washington, DC: National Academy Press; 2001. p. 82–161.Google Scholar
- 14.Singh RB, Niaz MA, Bishnoi I, et al. Diet, antioxidant vitamins, oxidative stress and risk of coronary artery disease: the Peerzada prospective study. Int J Cardiol. 1994;5:453–67.Google Scholar
- 16.Viroonudomphol D, Pongpaew P, Tungtrongchitr R. The relationships between anthropometric measurements, serum vitamin A and E concentrations and lipid profiles in overweight and obese subjects. Asia Pac J Clin Nutr. 2003;1:73–9.Google Scholar
- 23.Sarni RO, Ramalho RA. Serum retinol and total carotene concentrations in obese children. Med Sci Monit. 2005;11:510–4.Google Scholar
- 24.WHO. Obesity: preventing and managing the global epidemic. Report of WHO consultation on obesity. Geneva: World Health Organization; 1998.Google Scholar
- 26.WHO. Global prevalence of vitamin A. Indicators for assessing vitamin A deficiency and their application in monitoring and evaluating intervention programmers. Micronutrient Series, WHO/NUT. 10. Geneva: WHO; 1996.Google Scholar
- 27.Sommer A. La carencia de vitamina A y sus consecuencias. Guía práctica para la detección y el tratamiento Vitamin A deficiency and its consequences. Practical guide for detection and treatment). Genebra: OMS; 1995.Google Scholar
- 28.International Vitamin A Consultative Group (IVACG). IVACG Statement. Maternal night blindness: a new indicator of vitamin A deficiency. Washington, DC: IVACG; 2002.Google Scholar
- 30.IV Diretriz Brasileira Sobre Dislipidemias e Prevenção da Aterosclerose (IV Brazilian Guideline on Dyslipidemias and Prevention of Atherosclerosis). Arq Bras Cardiol. 2007;88:s.1.Google Scholar
- 34.Queiróz E, Ramalho RA, et al. Vitamin A status in diabetic children. Diabetes Nutr Metab. 2000;4:125–7.Google Scholar
- 36.Baltasar A. Definición: ¿Qué es la obesidad grave? (What is severe obesity?). In: Obesidad y Cirugía - como dejar de ser obeso (Obesity and Surgery—how not to be obese any longer). 1st ed. Madrid: Editora Arán; 2000. p. 15–21.Google Scholar
- 37.Polacow VO, Lancha AH Jr. Dietas hiperglicídicas: efeitos da substituição isoernergética de gordura por carboidratos sobre o metabolismo de lipídios, adiposidade corporal e sua associação com atividade física e com o risco de doença cardiovascular (Hyperglicidic diets: effects of isoenergetic substitutions of fat by carbohydrates on lipid metabolism, body adiposity and their association with physical activity and with the risk for cardiovascular disease). Arq Bras Endocrinol Metabol. 2007;51:389–400.CrossRefGoogle Scholar
- 38.Sorensen TI. The changing lifestyle in the world: body weight and what else? Diabetes Care. 2000;2:1–4.Google Scholar
- 42.Ramalho RA, Flores H, Accioly E, et al. Deficiência de vitamina A no Brasil (Deficiency of vitamin A in Brazil). Soc Iber Nutr. 2005.Google Scholar
- 47.Rhode B, McLean LD. Vitamin and mineral supplementation after gastric bypass. In: Deitel M, editor. (Chapter 19 Update) Surgery for the morbidly obese patient. Toronto: F-D Communications; 2000.Google Scholar
- 48.Cambi MPC. Avaliação nutricional e de qualidade de vida em pacientes submetidos à cirurgia bariátrica Nutritional and life quality assessment of patients submitted to bariatric surgery). Master thesis of the Post-Graduation. Program - UFSC: Florianópolis; 2001.Google Scholar
- 51.Zemora S, Diego J. Antioxidantes. Micronutrientes en lucha por la salud (Antioxidants. Micronutrients in fight for health). Rev Chil Nutr. 2007;34:17–26.Google Scholar
- 53.Carvalho OS, Moreira CLCB, et al. Cirurgia bariátrica cura síndrome metabólica? (Does bariatric surgery cure metabolic syndrome?). Arq Bras Endocrinol Metabol. 2007;51:78–85.Google Scholar
- 54.National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). National Cholesterol Education Program National Heart, Lung, and Blood Institute. Bethesda: National Institutes of Health NIH Publication; 2002.Google Scholar
- 55.Leborgne L, Maziere JC, Maziere C. Oxidative stress, atherogenesis and cardiovascular risk factors. Arch Mal Coeur Vaiss. 2002;9:805–14.Google Scholar
- 59.Santos HS, Cruz WM. A terapia nutricional com vitaminas oxidantes e o tratamento quimioterápico oncológico (Nutritional therapy with oxidant vitamins and the oncological chimiotherapic treatment). Rev Bras Cancerol. 2001;3:303–8.Google Scholar